Copyright
©The Author(s) 2016.
World J Gastrointest Oncol. Sep 15, 2016; 8(9): 695-706
Published online Sep 15, 2016. doi: 10.4251/wjgo.v8.i9.695
Published online Sep 15, 2016. doi: 10.4251/wjgo.v8.i9.695
Group I (n = 45) | Group II (n = 42) | P value | |
Age (mean ± SD) | 53.7 ± 13.4 | 58 ± 13.2 | 0.82 |
Sex (male/female) | 32/13 | 31/11 | 0.62 |
Localization of tumor from the anal verge (cm) (mean ± SD) | 5.6 ± 3 | 6.1 ± 2.8 | 0.39 |
T stage (2-4) | 8/28/9 | 6/32/4 | 0.56 |
Stage (II/III) | 4/41 | 5/37 | 0.53 |
Preoperative radiation dose (Gy) (mean) | 49.5 ± 1.99 | 49.5 ± 2 | 0.78 |
Follow-up time (mo) (mean ± SD) | 37.2 ± 19.6 | 31.1 ± 20.7 | 0.51 |
- Citation: Mihmanlı M, Kabul Gürbulak E, Akgün İE, Celayir MF, Yazıcı P, Tunçel D, Bek TT, Öz A, Ömeroğlu S. Delaying surgery after neoadjuvant chemoradiotherapy improves prognosis of rectal cancer. World J Gastrointest Oncol 2016; 8(9): 695-706
- URL: https://www.wjgnet.com/1948-5204/full/v8/i9/695.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v8.i9.695